Home > News > Starpharma: A Buying Opportunity?
June 22nd, 2006
Starpharma: A Buying Opportunity?
Jack Uldrich: Yesterday, shares of Starpharma’s ADR (Advance Deposit Receipts) plummetted 25 percent on no discernible news. I was surprised and disappointed by the drop — especially because I had just bought more shares the other day when the stock (Nasdaq: SPHRY) was trading at $3.50 and I didn’t think it could go any lower.
ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016
Arrowhead to Present at Upcoming March Conferences March 1st, 2016
Speedy ion conduction in solid electrolytes clears road for advanced energy devices May 5th, 2016
Engineers create a better way to boil water -- with industrial, electronics applications May 5th, 2016
Clues on the path to a new lithium battery technology: Charging produces highly reactive singlet oxygen in lithium air batteries May 5th, 2016
Unique nano-capsules promise the targeted drug delivery: Russian scientists created unique nano-capsules for the targeted drug delivery May 5th, 2016
Nanometrics to Announce First Quarter Financial Results on April 26, 2016 April 5th, 2016
Nanometrics Achieves Record 3D-NAND Bookings Quarter: A Record 3D-NAND Bookings Quarter, both in Aggregate and for Each of Three Key Customers March 28th, 2016
Arrowhead to Webcast Fiscal 2015 Year End Results December 7th, 2015
Haydale Announce Year End Results November 3rd, 2015